AXGN · 10-Q · 2026Q1 · Full report

Geographic Revenue Shift

Axogen, Inc. · 2026-04-28 · Importance 37 · Surprise 6

Although Axogen markets products in the U.S., Canada, Germany, the U.K., Spain and other countries, the company states that it derives substantially all of its revenues from the U.S. Axogen’s commercial efforts, reimbursement wins and CMS coding changes are therefore primarily U.S.-focused and materially drive consolidated results. The international footprint appears secondary to U.S. hospital and ASC demand in the near term. This U.S. concentration implies revenue exposure to domestic payer and hospital dynamics.

Key facts

• The company offers nerve repair products in the U.S., Canada, Germany, the United Kingdom, Spain and several other countries